Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

NCT00703638 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Colorectal Cancer
Head and Neck Cancer
Lung Cancer
Mesothelioma
Pancreatic Cancer
Prostate Cancer
Sarcoma

Interventions

DRUG: cisplatin
DRUG: pemetrexed disodium
DRUG: sorafenib

Sponsor

Masonic Cancer Center, University of Minnesota